Does HSA cover tirzepatide?
Prescription tirzepatide (Mounjaro, Zepbound) is HSA-eligible when it treats a diagnosed condition like type 2 diabetes or obesity — not when it's for general weight loss.
What flips the answer
- Covered when
It's prescribed to treat a diagnosed condition such as type 2 diabetes or obesity.
- Not covered when
You're taking it for general weight loss or appearance without a diagnosis of a specific medical condition.
- Not covered when
There's no valid prescription — an HSA can't cover a drug you obtain without one.
Tirzepatide is a prescription drug sold as Mounjaro (for type 2 diabetes) and Zepbound (for obesity). A legally prescribed drug used to treat a specific medical condition is a qualified medical expense, so an HSA can pay for it in those cases with pre-tax dollars.
The distinction the IRS draws is between treating a disease and improving general health or appearance. A drug prescribed to treat diagnosed obesity or diabetes qualifies; a drug taken to lose weight for general well-being, without a physician's diagnosis of a specific condition, does not.
If your insurance covers part of the cost, the HSA can pick up your remaining out-of-pocket share. For a weight-management prescription, keeping the prescription and the diagnosis on record is what supports the expense if you're ever asked to substantiate it.
That's the general answer. Yours is written in your actual policy.
Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.
Check my policy →